Biogen moves to dismiss US Walgreen, Kroger's US antitrust claims over Tecfidera
MLex Summary: Biogen moved to dismiss US antitrust claims filed by Walgreen Co. and The Kroger Co. accusing it of illegally blocking competition from generic versions of its brand-name drug Tecfidera,...To view the full article, register now.
Already a subscriber? Click here to view full article